13G Filing: Barrett Ehrlich and Oncbiomune Pharmaceuticals, Inc (OBMP)

CUSIP No. 68235A101		13G/A		Page 5 of 6 Pages

Item 4.  Ownership.

Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.

	(a)		Amount beneficially owned:  5,097,843
	(b)		Percent of class:  9.9%
	(c)		Number of shares as to which the person has:  5,097,843
			(i)	Sole power to vote or to direct the vote  5,097,843
			(ii)	Shared power to vote or to direct the vote  -0-
			(iii)	Sole power to dispose or to direct the disposition of  5,097,843
			(iv)	Shared power to dispose or to direct the disposition of  -0-

Instruction. For computations regarding securities which represent
a right to acquire an underlying security see §240.13d-3(d)(1).

Item 5.  Ownership
of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check
the following     ☐.

Item 6.  Ownership
of More than Five Percent on Behalf of Another Person.

NOT
APPLICABLE

Item 7.  Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

NOT
APPLICABLE

Item 8.  Identification
and Classification of Members of the Group.

NOT
APPLICABLE

Item 9.  Notice of
Dissolution of Group.

NOT
APPLICABLE